• GOP Flatlines Healthcare Vote, Despite Trump's Ultimatum

    Just as the House was expected to vote on the GOP's healthcare plan, which was designed to replace the now seven-year-old Affordable Care Act known as Obamacare, House Speaker Paul Ryan (R-WI) pulled the measure from a scheduled Friday afternoon vote. The decision to cancel the vote came just a day after President Trump laid down an ultimatum for House Republicans to either vote for the bill on Friday, or Obamacare would stand.Amanda Pedersen Healthcare policy is hard, and ultimatums don't...
  • Should you track adverse events differently?

    A new solution allows users to track compliance pertaining to events and corrective actions using either mobile devices or via Web browsers. Daphne AllenManaging corrective actions is one of medtech companies’ most complex tasks. Many companies, however, continue to use simple solutions like spreadsheets, observed Joseph Randazzo, Vice President of Strategic Growth for EtQ.“About 3 years ago we noticed that not a lot of medium-sized companies were being served by a typical quality suite,”...
  • Bos Sci's Synergy Stent Beats Promus on Safety

    Study shows Boston Scientific's bioabsorbable-polymer drug-eluting stent yields fewer blood clots than its Promus stent. Nancy Crotti EVOLVE II data showed Boston Scientific's Synergy bioabsorbable-polymer-coated drug-eluting stent is safer than the company's Promus Element Plus stent, which is coated with a permanent polymer. A drug-eluting stent coated with a bioabsorbable polymer may reduce the likelihood of blood clot formation and heart attack one year or more after...
  • Are Surgical Robots the Future or Just a Fad?

    Surgical robotics systems stole the show at this year's annual meeting of the American Academy of Orthopaedic Surgeons, but analysts are struggling to assess what the rate of adoption and peak penetration will be for these robots.Amanda PedersenZimmer Biomet said it plans to launch its Rosa total knee application within 18 months. Surgical robots dominated the annual meeting of the American Academy of Orthopaedic Surgeons as Stryker launched its highly anticipated Mako total knee...
  • PQ Bypass Snagged CE Mark for Trio of Devices

    PQ Bypass has developed a trio of devices designed to help doctors perform a fully percutaneous femoral popliteal bypass in patients with extremely long lesions in their superficial femoral artery due to peripheral arterial disease. The new devices now have CE mark approval in Europe.Amanda Pedersen The PQ Stent Graft System is designed for flexibility and robust durability to help maintain an open lumen. The device is one of three that are used during the PQ Detour procedure. PQ...
  • State of the Latin American Dental Bone Graft Substitute Market

    The market for dental bone graft substitutes in Latin America is being shaped by technological innovation and attempts to reduce disease transmission. Salma Mashkoor and Jeffrey WongThe Latin American market for dental bone graft substitutes includes the bone graft substitute and dental membrane markets in Brazil, Argentina, and Mexico. These markets are growing in response to technological innovation, as well as ongoing attempts to reduce disease transmission. However, a lack of government...
  • How a New App is Helping Babies (and Parents) Get More Sleep

    A collaboration between Johnson & Johnson Consumer Inc. and Rest Devices Inc. demonstrates what can be accomplished when a large corporation like J&J pairs up with a small startup. The companies recently launched a smart, personalized baby sleep coaching app called Nod, that leverages Rest Devices' Mimo Baby wearable monitor, and J&J's clinicall-validated behavioral technqiues developed by pediatric sleep experts.Amanda PedersenJohnson & Johnson Consumer Inc. collaborated with...
  • How a pH Indicator Made Blood Typing Faster, Cheaper

    Chinese researchers believe their new, paper-based test could be used in war zones and remote locationsNancy Crotti Chinese researchers have developed a speedy paper blood-type test using a common pH indicator.The researchers used antibodies immobilized on paper test strips to separate red blood cells and plasma from small volumes (100 μl) of whole, uncentrifuged blood samples. The pH indicator, bromocresol green dye, revealed color changes that indicatedA and/or B antigens on red blood...
  • Would Medtech Feel the Pain of Trump Budget Cuts?

    The NIH would absorb a painful $5.8 billion cut under President Trump's first budget proposal, and double the amount of user fees FDA collects from drug and device makers.Amanda Pedersen President Donald Trump’s plan to make America great again involves major slashes to the National Institutes of Health budget, and doubling the amount of user fees FDA would collect from drug and device makers.Hear AdvaMed President and CEO Scott Whittaker's keynote address at BIOMEDevice Boston, May 3-4,...
  • Total-body PET, Find Out What it Means to Thee

    Researchers have NIH funding and industry partners for a total-body PET machine that could work faster and produce better images. Nancy Crotti U.S. and British researchers are closing in on creating a total-body positron emission tomography (PET) scanner that would work faster and with less radiation to produce higher-resolution images than are currently available.Don't miss BIOMEDevice Boston, May 3-4, 2017.Led by Simon Cherry and Ramsey Badawi of the University of California, Davis...
  • 60-Second HIV Test Receives “Innovative Technology” Award and Contract

    The 60-second rapid HIV test, INSTI, receives innovative technology award.By Daphne AllenHIV-positive patients may not always know they are infected. Routine screening has been a challenge, but one potential solution has just won an innovative technology award and a group purchasing contract with one of the largest healthcare services companies in the United States.In its ongoing effort to enhance patient care and safety, healthcare services company Vizient Inc. has awarded a contract to...
  • Could MRI Take Robotic Medicine to the Next Level?

    Researchers are developing tiny MRI-guided robots that could someday be used to deliver drugs or to self-assemble to form interventional tools for more targeted treatment options. Kristopher SturgisResearchers in Houston are working on a new approach to drug delivery using MRI-guided mini robots. Robotics in medicine could soon be taking the next big leap forward, thanks to a new approach to drug delivery with a technology designed to harness the power of MRI to guide dozens...
  • How Medtronic Made a Smarter Heart Monitor

    After Medtronic released its Reveal Linq insertable cardiac monitor in 2014, the company immediately wanted to make the device better. This week a Medtronic manager told Qmed & MDDI about the aggressive timeline the R&D team followed to deliver a more accurate version of the device, which just received FDA clearance. Amanda PedersenMedtronic launched Reveal Linq in 2014, which was lauded as the smallest insertable cardiac monitor on the market. Now the company has FDA clearance for...
  • Are Medtech Stocks 'Trumping' Pharma?

    Public medtech companies seem to be benefitting from investor skittishness toward pharmaceutical and biotech stocks as President Trump continues to criticize high drug prices. Amanda Pedersen In January, during his first formal press conference as president, Trump said drug companies were “getting away with murder,” and also blasted them for moving production outside of the country. A tweet last week added salt to that open wound, as the president indicated said he is working on a new...
  • Favorable Reimbursement Drives European Neuromodulation Device Market

    With only a small fraction of the potential patient population currently being treated, the neuromodulation market is poised for growth.Beverly Allan and Kamran ZamanianNeuromodulation is the most lucrative sector in the Europe neurological device market, accounting for over half of the revenue.1  The market is forecasted to continue growing over the next decade, as only a small fraction of the potential patient population is currently being treated with neuromoduation technology and the...
  • Could Trump's Pick for FDA Mean Faster Approvals?

    The industry has been quick to throw its support behind Scott Gottlieb, President Trump's pick to run FDA. Gottlieb has a history of advocating for faster FDA approvals and stronger regulatory transparency.Amanda PedersenScott Gottlieb has won medtech over, will he also win over the Senate? Known for pushing regulatory transparency and policies that support medical innovation and entrepreneurship, Scott Gottlieb, President Trump's pick to head FDA, has already won over many industry...
  • J&J Could Axe 400 Scottish Jobs

    Up to 400 workers at a Johnson & Johnson surgical suture plant in Scotland could be out of work. The company said it will close the plant as part of its medical devices unit restructuring plans revealed last year. The suture facility accounts for less than 6% of the company's global capacity.Amanda Pedersen  Johnson & Johnson revealed plans last year to eliminate up to 6% of its medical device workforce, but the company stopped short of saying exactly what jobs would be on the...
  • How Graphene Could Enable Cheap Diagnostic Devices

    Researchers found a way to capture and analyze individual blood cells that could be used to make a variety of diagnostic devices for as little as $5 each.  Kristopher SturgisMild heating of graphene oxide sheets makes it possible to bond particular compounds to the sheets' surface. These compounds in turn select and bond specific molecules of interest, including DNA and proteins, or even whole cells. In this image, the treated graphene oxide on the right is nearly twice as efficient at...
  • Are Edwards and Bos Sci Headed for Cross-Licensing?

    Germany ruling suggests that the lengthy patent battle between Boston Scientific and Edwards Lifesciences may end in a cross-licensing agreement.Amanda Pedersen A cross-licensing agreement may inevitably be in Edwards Lifesciences' and Boston Scientific's future, but for now the two companies are still going toe-to-toe with one another over patent litigation related to transcatheter aortic valve replacement (TAVR) technology.Learn from industry leaders at BIOMEDevice Boston, May 3-4, 2017....
  • FDA Approves Stent for Troublesome Cardiac Artery Lesions

    The Tryton side-branch stent is compatible with stents manufactured to treat lesions in the main coronary artery, according to its North Carolina manufacturer.Nancy CrottiTryton Medical's side-branch stent is designed to treat, protect, and secure bifurcation lesions and integrates into any conventional drug-eluting main vessel stent.  FDA has approved a stent to treat plaque buildup in side branches of coronary arteries, nine years after the device received the CE mark in Europe....